Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Obese women with PCOS are more likely to have fatty liver disease.

Melatonin improved mental health and metabolism in women with PCOS.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

PCOS is a common hormonal disorder in women, marked by high androgen levels and often seen in 20% of women via ultrasound.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Curcumin may improve blood sugar levels and cholesterol in people with PCOS, but more research is needed.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.